NP Thyroid 15
NP Thyroid 15
Approved
Approval ID
a3ff93ad-86ed-4324-ae86-7e7ed3a49db8
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 18, 2023
Manufacturers
FDA
Acella Pharmaceuticals, LLC
DUNS: 825380939
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
LEVOTHYROXINE, LIOTHYRONINE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code42192-327
Product Classification
G
Generic Name
LEVOTHYROXINE, LIOTHYRONINE
Product Specifications
Route of AdministrationORAL
Effective DateApril 18, 2023
FDA Product Classification
INGREDIENTS (5)
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
LEVOTHYROXINEActive
Quantity: 9.5 ug in 1 1
Code: Q51BO43MG4
Classification: ACTIB
DEXTROSE MONOHYDRATEInactive
Code: LX22YL083G
Classification: IACT
LIOTHYRONINEActive
Quantity: 2.25 ug in 1 1
Code: 06LU7C9H1V
Classification: ACTIB